• SISAQOL press release - illustration
    Categories: , ,

    PRESS RELEASE: Generating recommendations for the design, analysis and interpretation of patient- reported outcome (PRO) data for cancer clinical trials: the launch of SISAQOL-IMI

    17 Feb 2021

  • EU flag
    Categories:

    When will the EU take treatment optimisation seriously?

    15 Feb 2021

  • EORTC membership renewal programme - illustration
    Categories:

    EORTC embarked on a membership renewal programme

    5 Feb 2021

  • What has been the impact of COVID-19 on clinical cancer research?
    Categories:

    Interview of EORTC members about COVID-19 impact on cancer clinical trials

    4 Feb 2021

  • EORTC 1945 OligoRARE trial
    Categories: ,

    PRESS RELEASE: EORTC 1945 OligoRARE trial in oligometastatic rare cancers receives support by Anticancer Fund & Rising Tide Foundation

    2 Feb 2021

  • lung-x-ray
    Categories: , ,

    PRESS RELEASE: First Patients Tested with InVisionFirst®-Lung in EORTC Sponsored Phase II NSCLC Study

    20 Jan 2021

  • EORTC and BioMed Alliance webinar - banner
    Categories:

    Webinar: How can current EU policy initiatives pave the way towards treatment optimisation as part of health systems?

    14 Jan 2021

  • Doctor discussing with a patient
    Categories:

    EORTC lobbies for reducing the economic burden of cancer by optimising treatment for cancer patients

    17 Dec 2020